Peter Olagunju is Chief Operating Officer of Tcr2 Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
TCR2 THERAPEUTICS INC.
1 Jun 23
4
TCR2 THERAPEUTICS INC.
19 Dec 22
4
TCR2 THERAPEUTICS INC.
13 Dec 22
4
TCR2 THERAPEUTICS INC.
9 Dec 22
4
TCR2 THERAPEUTICS INC.
7 Dec 22
4
TCR2 THERAPEUTICS INC.
5 Dec 22
4
TCR2 THERAPEUTICS INC.
18 Nov 22
4
TCR2 THERAPEUTICS INC.
10 Dec 21
4
TCR2 THERAPEUTICS INC.
27 Jul 21
3
TCR2 THERAPEUTICS INC.
27 Jul 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Jun 23 | TCRR Tcr2 Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 24,092 | 0.00 | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 62,047 | 0.00 | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 16,354 | 0.00 | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.21 | 47,100 | 245.39 k | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.97 | 98,124 | 95.18 k | 0 |